Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126491651 | 12649165 | 1 | I | 20160303 | 20160801 | 20160812 | 20160812 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-063816 | BRISTOL MYERS SQUIBB | 67.28 | YR | F | Y | 0.00000 | 20160812 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126491651 | 12649165 | 1 | PS | COUMADINE | WARFARIN SODIUM | 1 | Oral | 1 DF, QD | Y | 9218 | 1 | DF | TABLET | QD | |||||
| 126491651 | 12649165 | 2 | SS | COLCHIMAX /01722001/ | COLCHICINEOPIUMTIEMONIUM METHYLSULFATE | 1 | Oral | Y | 0 | ||||||||||
| 126491651 | 12649165 | 3 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 126491651 | 12649165 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 126491651 | 12649165 | 5 | C | CALCIDIA | CALCIUM POLYCARBOPHIL | 1 | Oral | 3 DF, QD | U | 0 | 3 | DF | QD | ||||||
| 126491651 | 12649165 | 6 | C | RILMENIDINE | RILMENIDINE | 1 | Oral | 1 MG, QD | U | 0 | 1 | MG | QD | ||||||
| 126491651 | 12649165 | 7 | C | AMIODARONE HYDROCHLORIDE. | AMIODARONE HYDROCHLORIDE | 1 | Oral | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
| 126491651 | 12649165 | 8 | C | LASILIX /00032601/ | FUROSEMIDE | 1 | Oral | 1 DF, BID | U | 0 | 1 | DF | BID | ||||||
| 126491651 | 12649165 | 9 | C | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | Oral | UNK, QD | U | 0 | QD | ||||||||
| 126491651 | 12649165 | 10 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | QD | ||||||
| 126491651 | 12649165 | 11 | C | TARDYFERON | FERROUS SULFATE | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | COATED TABLET | QD | |||||
| 126491651 | 12649165 | 12 | C | PERINDOPRIL | PERINDOPRIL | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126491651 | 12649165 | 1 | Atrial fibrillation |
| 126491651 | 12649165 | 2 | Pain |
| 126491651 | 12649165 | 3 | Product used for unknown indication |
| 126491651 | 12649165 | 4 | Product used for unknown indication |
| 126491651 | 12649165 | 5 | Product used for unknown indication |
| 126491651 | 12649165 | 6 | Product used for unknown indication |
| 126491651 | 12649165 | 7 | Product used for unknown indication |
| 126491651 | 12649165 | 8 | Product used for unknown indication |
| 126491651 | 12649165 | 9 | Product used for unknown indication |
| 126491651 | 12649165 | 10 | Product used for unknown indication |
| 126491651 | 12649165 | 11 | Product used for unknown indication |
| 126491651 | 12649165 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126491651 | 12649165 | HO |
| 126491651 | 12649165 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126491651 | 12649165 | Chondrocalcinosis | |
| 126491651 | 12649165 | Drug interaction | |
| 126491651 | 12649165 | Haemarthrosis | |
| 126491651 | 12649165 | International normalised ratio increased | |
| 126491651 | 12649165 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |